LCID
Lucid Group, Inc.
LCID offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
MAR
Marriott International, Inc.
MAR has a slight edge over LCID overall, supported by lower modeled downside.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
MAR Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Strong | |
| Unavailable |
MAR's profitability and cash flow are currently healthy, and its revenue is stable. There isn't enough data to rate its balance sheet.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
MAR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 23x | $235 | -45% |
| Fair | 31x | $306 | -28% |
| Forward | 33x | $425 | — |
| Current | 42x | $425 | — |
| Expensive | 53x | $529 | +24% |
Historical ranges are pointers, not guarantees.
MAR's PE is in its expensive range at 42x. If earnings grow as analysts expect, today's price would be 33x next year's earnings, in its fair range.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
MAR Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for MAR, with profitability improving.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
MAR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $12.98 | +29% |
| Q3 2026 | $10.04 | +5.9% |
| Q2 2026 | $9.67 | +8.9% |
| Q1 2026 | $9.55 | +8.6% |
| Q4 2025 | $9.51 | +14% |
| Q3 2025 | $9.48 | -0.7% |
| Q2 2025 | $8.88 | -11% |
| Q1 2025 | $8.79 | -9.2% |
| Q4 2024 | $8.33 | -18% |
MAR has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over MAR on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
MAR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $7B | +8% |
| Q2 2026 | $7.1B | +4.8% |
| Q1 2026 | $6.7B | +6.2% |
| Q4 2025 | $6.7B | +4.1% |
| Q3 2025 | $6.5B | +3.7% |
| Q2 2025 | $6.7B | +4.7% |
| Q1 2025 | $6.3B | +4.8% |
| Q4 2024 | $6.4B | +5.5% |
MAR's revenue has grown year over year for 22 quarters in a row: $7B last quarter, up 8% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 18% | 0 points |
| Q2 2026 | 17% | -0.9 points |
| Q1 2026 | 16% | +0.8 points |
| Q4 2025 | 12% | -0.1 points |
| Q3 2025 | 18% | +3.1 points |
| Q2 2025 | 18% | -0.2 points |
| Q1 2025 | 15% | +0.5 points |
| Q4 2024 | 12% | -0.1 points |
MAR has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
MAR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.3B | +37% |
| Q2 2026 | $796M | +63% |
| Q1 2026 | $728M | +42% |
| Q4 2025 | $657M | +$681M |
| Q3 2025 | $951M | +35% |
| Q2 2025 | $488M | -25% |
| Q1 2025 | $512M | -24% |
| Q4 2024 | -$24M | -104% |
MAR has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
MAR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.2% | -3.3M shares |
| 1 year | -4.1% | -11.3M shares |
| 3 years | -13% | -38.9M shares |
| 5 years | -21% | -68.1M shares |
| Available history | -22% | -74.3M shares |
MAR has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.3B |
| Q2 2026 | $1.1B |
| Q1 2026 | $700M |
| Q4 2025 | $1B |
| Q3 2025 | $800M |
| Q2 2025 | $749M |
| Q1 2025 | $751M |
| Q4 2024 | $586M |
MAR spent $4.1B buying back its own shares over the past year, up 41% from the year before.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
MAR Net Leverage
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
MAR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 72.9 | Overbought |
| Stochastic | 89.3 | Overbought |
MAR's weekly RSI is 73 (overbought) and its Stochastic is 89 (overbought).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
MAR PE vs Consumer Cyclical Sector
| Metric | MAR | Sector median | Relative |
|---|---|---|---|
| PE | 42x | 18x | 135% above |
| PE % | 81 | 47 | 34 pts above |
MAR is trading at 42x earnings, a 135% premium to the Consumer Cyclical sector's median of 18x.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
MAR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $387.0 | 9.7% above |
| 20 week MA | $369.3 | 15% above |
| 50 week MA | $353.3 | 20% above |
| 100 week MA | $310.1 | 37% above |
| 200 week MA | $263.5 | 61% above |
MAR has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
MAR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $152.7 | $128.8 | -16% |
| 2021 | $128.8 | $165.2 | +28% |
| 2022 | $165.2 | $148.6 | -10% |
| 2023 | $148.6 | $225.5 | +52% |
| 2024 | $225.5 | $283.7 | +26% |
| 2025 | $283.7 | $315.6 | +11% |
| 2026 YTD | $315.6 | $424.7 | +35% |
MAR has the edge over LCID on returns for 2026, with the stronger performance.